Watch on-demand to ensure you’re equipped with the QC skills, technology and guidance needed to release safe cell and gene therapies.
Cell and gene therapies are critical emerging treatment modalities with the potential to tackle and cure conditions from life-limiting genetic disorders to cancers. However, being novel, biological and potentially personalised presents a whole range of quality control challenges. During this conference expert speakers addressed the critical element of microbiological safety and control.
Listen to leading cell and gene therapy quality control experts to discover how the industry is rapidly advancing ways to ensure microbiological QC testing can keep up with these complex therapies.
Our line-up of industry leading speakers elaborate on the risks of inadequate microbial testing during the manufacture of cell and gene therapies, addressing how they can be mitigated to ensure patient safety. This event is for manufacturing and quality control personnel looking to:
Watch on-demand to hear from QC experts on best practices, and to explore technological advances that can support the efficient release of safe cell and gene therapies.
We’ve curated an exciting and topical agenda of webinars and keynote sessions for you.
Connect with all your fellow attendees and potential new partners through our dedicated online meetings platform and networking sessions. Pre-schedule or conduct instant video meetings.
Instant access to industry professions, new developments and interact in real time.
Join experts for interactive product demonstrations, Q&A’s and in depth analysis.
Online event took place on 13 July 2022. Watch now on-demand.